Spiderwort Inc. - Company Research Report

Company Overview

Name

Spiderwort Inc.

Mission

Spiderwort Inc. aims to build the framework for the future of regenerative medicine through the development of innovative plant-based biomaterials to support the repair and regeneration of living tissues.

Founded and Founders

No information is available.

Key People

Charles M. Cuerrier, PhD: Co-founder and Chief Executive Officer (CEO)

Andrew E. Pelling, PhD, FRSB: Co-founder and Chief Scientific Officer (CSO)

Stephen Hanson, PhD, MBA: Business Development Director

Scott Jarvis, CPA: Chief Financial Officer (CFO)

Headquarters

Location 1: 7 Bayview Station Road, Ottawa, Ontario, K1Y 2C5

Location 2: 283, boulevard Alexandre-Taché (F3006), Gatineau, Québec, J9A 1L8

Number of Employees

No information is available.

Revenue

No information is available.

Known For

Spiderwort Inc. is known for its transformative platform of cellulose-based biomaterials that serve as scaffolds for regenerative medicine, including the treatment of spinal cord injuries and soft tissue regeneration.

Products

Overview

Spiderwort’s proprietary plant-based biomaterial platform aims to advance regenerative medicine, tissue engineering, and medical aesthetics. The company's medical devices are currently under development and are not commercially available.

CelluBridge™

Description: A cellulose-based scaffold under development to support repair and regeneration of the spinal cord. Recognized by the U.S. Food and Drug Administration with a Breakthrough Device designation.

Key Features:

Plant-based

Scalable

Supports locomotor recovery in pre-clinical studies

Provides a natural scaffold for tissue growth

CelluJuve®

Description: A cellulose-based dermal filler under development for facial tissue augmentation and rejuvenation.

Key Features:

Plant-based

Eco-friendly

Promotes healing

Cosmetic restoration

Formulated without a crosslinker

Supports collagen deposition and healthy tissue growth

Recent Developments

New Products Launched

No new products have been commercially launched as their offerings are still under development.

New Features Added to Existing Products

No information is available.

New Partnerships

Techcracker 2024: Spiderwort’s co-founders participated in the Techcracker 2024 in Japan, showcasing their advancements and engaging in collaborative discussions.

IMCAS World Congress 2024: Attended the IMCAS World Congress in Paris, France, to present their CelluJuve product initiative.

Other Developments

April 8, 2024: Co-founders attended Techcracker 2024 in Japan.

January 25, 2024: Attendance at IMCAS World Congress 2024 in Paris.

December 21, 2023: Year in review highlighting advancements in regenerative medicine.

December 5, 2023: Introduction of CelluJuve® Clinical Advisory Board.

November 28, 2023: Executive joins Canada's premier biotech leadership development program.

November 22, 2023: Selected to join Elite CELS Valley Ready Program.

October 27, 2023: European tour focused on building global partnerships.

June 6, 2023: Accepted to MaRS Health Science Portfolio Tech Accelerator.

February 7, 2023: Won Judge's Choice Award at Octane Medical Aesthetics Tech Forum.

February 2, 2023: Subsidiary, Whiteboard Foods, withdrew from XPRIZE's Feed The Next Billion competition.

This detailed report provides a comprehensive view of Spiderwort Inc.'s mission, product offerings, key personnel, and recent developments, reflecting the company's dedication to innovation in regenerative medicine.